ライフサイエンスコーパス: alpha-2 adrenergic receptor

1 ously defined constitutive activation of the alpha 2-adrenergic receptor.

2 otein expression of NE transporter (NET) and alpha(2) adrenergic receptor.

3 that control song contain high densities of alpha(2)adrenergic receptors.

4 a(1)- and beta-adrenergic receptors, but not alpha(2)-adrenergic receptors.

5 ted secretion, in the cell surface export of alpha(2)-adrenergic receptors.

6 hat it is primarily mediated by postsynaptic alpha(2)-adrenergic receptors.

7 morphisms of the adenosine A2A receptors and alpha(2)-adrenergic receptors.

8 These findings provide evidence that alpha 2-adrenergic receptors activate PLC in DCT cells t

9 olin-stimulated cAMP accumulation induced by alpha(2)-adrenergic receptor activation is altered follo

10 Our data implicate alpha-2 adrenergic receptor activity in regulating IKBKA

11 Using clonidine, an alpha 2-adrenergic receptor agonist, as a probe of NA fu

12 ed the impact of a dexmedetomidine infusion (alpha(2)-adrenergic receptor agonist) on muscle sympathe

13 This study tests whether clonidine, an alpha(2)-adrenergic receptor agonist, alters excitatory

14 ergic receptor antagonist, prazosin, and the alpha(2)-adrenergic receptor agonist, clonidine, reduced

15 ng a baseline condition and an infusion of a alpha(2)-adrenergic receptor agonist, dexmedetomidine (1

16 ne content in the pancreas and blocked by an alpha(2)-adrenergic receptor agonist, implicating functi

17 ohimbine (1.0 microm), and attenuated by the alpha(2)-adrenergic receptor agonist, UK 14,304 (1.0 mic

18 otein kinase activity induced by UK14304, an alpha(2)-adrenergic receptor agonist.

19 Dexmedetomidine (DEX; Precedex) is an alpha-2 adrenergic receptor agonist that produces anxiol

20 Ang II-sensitive cells were inhibited by alpha 2-adrenergic receptor agonists (12 of 15 neurons).

21 e is reduced responsiveness to alpha(1)- and alpha(2)-adrenergic receptor agonists in skeletal muscle

22 tially localized apically, whereas the three alpha 2-adrenergic receptor (alpha 2 AR) subtypes are lo

23 mically the distribution of the A subtype of alpha 2-adrenergic receptor (alpha 2A-AR) in the rat cen

24 alpha 2-Adrenergic receptors (alpha 2-ARs) respond to no

25 Activation of alpha 2-adrenergic receptors (alpha 2AR) in the cerebral

26 sly identified spinophilin as a regulator of alpha(2) adrenergic receptor (alpha(2)AR) trafficking an

27 receptor) and inhibitory (Galpha(i)-mediated alpha(2)-adrenergic receptor (alpha(2)-AR)) signals to a

28 The alpha(2)-adrenergic receptor (alpha(2)AR) subtypes A and

29 d the role of the extracellular N termini of alpha(2)-adrenergic receptors (alpha(2)-ARs) in the ante

30 The alpha(2)-adrenergic receptors (alpha(2)-ARs) modulate no

31 olateral localization and trafficking of the alpha(2)-adrenergic receptors (alpha(2)AR) are not; inst

32 alpha(2)-adrenergic receptors (alpha(2)AR) couple to mul

33 everal studies have shown that activation of alpha(2)-adrenergic receptors (alpha(2)ARs) leads to mil

34 The alpha(2)-adrenergic receptors (alpha(2)ARs) play a criti

35 For the treatment of glaucoma, alpha-2 adrenergic receptor (alpha 2-AR) agonists are th

36 Alpha-2-adrenergic receptor (alpha2-AR) agonists potentl

37 Norepinephrine and CGRP act through the alpha(2)-adrenergic receptor and CGRP receptor, respecti

38 Concurrently, alpha(2)-adrenergic receptor and TNFalpha-induced inhibi

39 y stenosis before and during infusion of the alpha 2-adrenergic receptor antagonist idazoxan (1.0 mic

40 (iv) NA overflow for MA was enhanced by the alpha(2)-adrenergic receptor antagonist, yohimbine (1.0

41 t of human melanocyte cell cultures with the alpha-2 adrenergic receptor antagonist yohimbine results

42 mmonis 3 (CA3) epileptiform activity through alpha(2) adrenergic receptor (AR) activation on pyramida

43 regulating trafficking and signaling of the alpha(2)-adrenergic receptor (AR) both in vitro and in v

44 In NIH-3T3 alpha(2)-adrenergic receptor (AR) transfectants, the alp

45 The effects of alpha 2-adrenergic receptors are usually attributed to i

46 beta- and alpha(2)-adrenergic receptors are known to exhibit subst

47 beta- and alpha 2-adrenergic receptors (ARs) couple positively and

48 Activation of G protein-coupled alpha(2) adrenergic receptors (ARs) inhibits epileptifor

49 Coactivation of spinal alpha(2)-adrenergic receptors (ARs) and opioid receptors

50 e activation of either supraspinal or spinal alpha(2) adrenergic receptors can induce antinociception

51 Chinese hamster ovary-K1 cells impaired the alpha(2)-adrenergic receptor G(s)-mediated stimulation o

52 ed: Galpha(oA) = Galpha(oB) > Galpha(i2) for alpha(2)-adrenergic receptor; Galpha(i2) > Galpha(oA) =

53 In this brain region, micro-opioid and alpha-2-adrenergic receptors have been shown to share th

54 Activation of alpha(2)-adrenergic receptors in the central nervous sys

55 T can regulate the density of alpha(2)adrenergic receptors in the avian brain, indicat

56 Blockade of alpha-2 adrenergic receptors increased the tactile and t

57 ast to that which occurs in the hippocampus, alpha(2)-adrenergic receptor inhibition of NE release is

58 Activation of the alpha(2)-adrenergic receptor is associated with modulati

59 gulates the Golgi to cell surface traffic of alpha(2)-adrenergic receptors, likely through a physical

60 on a natively expressed signalling pathway, alpha(2)-adrenergic receptor-mediated I(Ca) modulation,

61 NO attenuates alpha(2)-adrenergic receptor-mediated inhibition of aden

62 r nerve injury, the cascade of activation of alpha(2) adrenergic receptors-muscarinic receptors-NO in

63 Activation of the alpha(2)-adrenergic receptor on neurons regulates the ac

64 (3)R) was increased but not signaling of the alpha(2) adrenergic receptor or bradykinin BK(2) recepto

65 Activation of alpha(2)-adrenergic receptors or mu-opioid receptors red

66 ts suggest that spinal (but not supraspinal) alpha(2) adrenergic receptors play a significant role in

67 In addition, alpha(1)- and alpha(2)-adrenergic receptors, present in CA1, could pot

68 aused an approximate 50% decrease in NET and alpha(2) adrenergic receptor protein expression in sever

69 ine were mediated by ET(A), thromboxane, and alpha(2)-adrenergic receptors, respectively, and were in

70 tonin 5-HT1A, 5-HT2A, 5-HT uptake sites, and alpha 2-adrenergic receptor sites were measured.

71 l epithelial cells, all three epitope-tagged alpha 2-adrenergic receptor subtypes were found in neuro

72 -PCR was performed to detect the mRNA of the alpha(2)-adrenergic receptor subtypes alpha(2)A, alpha(2

73 ugh regulation of TNF expression, transforms alpha(2)-adrenergic receptors such that they function to

74 ation/down-regulation of the chromaffin cell alpha(2)-adrenergic receptors that normally inhibit CA s

75 trimers had little effect on the coupling of alpha(2)-adrenergic receptors to the VD pathway.

76 BRET signals were observed for AGS4-RLuc and alpha(2)-adrenergic receptor-Venus, which were Galpha(i)

77 Coupling to the alpha 2-adrenergic receptor was reconstituted in neurons

78 le in vivo interactions between dopamine and alpha(2)-adrenergic receptors was investigated in quail,

79 avian brain, indicating that the density of alpha(2) adrenergic receptors within the song system mig

80 volumes of song nuclei, and the densities of alpha(2) adrenergic receptors within the song system of

81 e largest, T was highest, and the density of alpha(2) adrenergic receptors (within HVc and RA) was lo